期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
A β-lactamase-activatable photosensitizer for the treatment of resistant bacterial infections
1
作者 Zhipeng Li qincong feng Jianliang Shen 《Chinese Chemical Letters》 SCIE CAS 2024年第11期402-405,共4页
Antibacterial agent of activatable photosensitizer not only has the advantages of traditional photosensitizers,such as good curative effect and low resistance,but also has better selectivity for bacteria and lower tox... Antibacterial agent of activatable photosensitizer not only has the advantages of traditional photosensitizers,such as good curative effect and low resistance,but also has better selectivity for bacteria and lower toxicity to normal tissues.Limited reports of activatable photosensitizer can be used to treat drugresistant bacteria.In order to meet this challenge,we designed and synthesized an activatable photosensitizer(Ce-OHOA),which can not only selectively identify methicillin-resistant Staphylococcus aureus(MRSA)with high expression ofβ-lactamase by fluorescence imaging,but also kill MRSA with less than10 times the concentration and 10 times the irradiation dose of CySG-2 reported.Ce-OHOA not only combines the dual functions of fluorescence diagnosis and photodynamic therapy,but also selectively acts on bacteria with high expression ofβ-lactamase and has little toxicity to normal cells.We expect that the study of this activating photosensitizer will provide a new solution for antibacterial photodynamic therapy(aPDT)of drug-resistant bacteria. 展开更多
关键词 Activatable photosensitizer MRSA β-Lactamase Fluorescence imaging aPDT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部